SUBSTITUTED CYCLOALKENE DERIVATIVE

    公开(公告)号:US20090233952A1

    公开(公告)日:2009-09-17

    申请号:US12066813

    申请日:2006-09-13

    摘要: [Object] To provide a substituted cycloalkene derivative having an action to suppress intracellular signal transduction or cell activation induced by endotoxin and to suppress cell responses due to the intracellular signal transduction and cell activation such as an excess generation of inflammatory mediators such as TNF-α, pharmacologically acceptable salts therefor, a medicament containing them as an active ingredient, a preparation method therefor, and a medicament containing the aforementioned substituted cycloalkene derivative as an active ingredient which is superior in prophylaxis and/or treatment of diseases such as sepsis (septic shock, disseminated intravascular coagulation, multiple organ failure and the like), that are associated with intracellular signal transduction or cell activation induced by endotoxin and to cell responses to the intracellular signal transduction and cell activation.[Solution] A compound represented by the general formula (I): {whereinX and Y represent a group in which X and Y together with a carbon atom to which they are bound form ring A (the ring is 3- to 7-membered heterocyclyl ring or 3- to 7-membered cycloalkyl ring), each represents a hydrogen atom, or X and Y together represent a substituent of ring B. l and m, independently from each other, represent an integer of 0 to 3, and l+m is 1 to 3. R1 is an aliphatic hydrocarbon group and the like which may be substituted with a group selected from Substituent group β and Substituent group γ. n represents an integer of 0 to 3. R2 is a C1-C6 alkyl group and the like which may be substituted with a group selected from a hydrogen atom and Substituent group β. R3 is a phenyl group, 5- to 6-membered heteroaryl group and the like which may be substituted with a group selected from Substituent group ε. R5 is a C1-C6 alkyl group and the like which may be substituted with a group selected from a hydrogen atom and Substituent group β. Provided that in the case where R3 is a phenyl group which may be substituted with a group selected from Substituent group ε, X and Y represent a group in which X and Y together with a carbon atom to which they are bound form ring A, or X and Y together represent a substituent of ring B.

    METHOD, DEVICE AND STRUCTURE FOR JOINING TWO MEMBERS TOGETHER
    2.
    发明申请
    METHOD, DEVICE AND STRUCTURE FOR JOINING TWO MEMBERS TOGETHER 审中-公开
    方法,用于接合两个成员的设备和结构

    公开(公告)号:US20090151146A1

    公开(公告)日:2009-06-18

    申请号:US12192439

    申请日:2008-08-15

    IPC分类号: B23P11/00 B21D39/03

    摘要: A method for joining a holed member, including a through-hole, and an unholed member together, the method includes deforming the unholed member against the through-hole of the holed member so that a flat portion of the holed member around the through-hole is deformed into the shape of a truncated conical projection and so that the unholed member is deformed along the truncated conical projection to partly project from the through-hole, and deforming a portion of the unholed member which projects from the through-hole to come into intimate contact with a wall surface of the through-hole of the holed member.

    摘要翻译: 一种用于将包括通孔和不合缝构件的孔构件接合在一起的方法包括使不通孔构件抵靠孔构件的通孔变形,使得孔构件在通孔周围的平坦部分 变形为截头圆锥形突起的形状,使得未开孔的构件沿着截头圆锥形突起变形,以从通孔部分地突出,并使从通孔突出的未凹陷构件的一部分变形 与孔洞构件的通孔的壁面紧密接触。

    Telomerase-inhibiting ENA oligonucleotide
    3.
    发明申请
    Telomerase-inhibiting ENA oligonucleotide 审中-公开
    端粒酶抑制性ENA寡核苷酸

    公开(公告)号:US20070117773A1

    公开(公告)日:2007-05-24

    申请号:US11604630

    申请日:2006-11-27

    IPC分类号: A61K48/00 C07H21/04

    摘要: A telomerase-inhibiting ENA oligonucleotide compound represented by a formula: E1-B1-B2-B3-B4-E2 (I), wherein E1 represents a group represented by the formula R1-; E2 represents a group represented by the formula -B7-R2; B4, B5, and B8 are identical or different, and each represents Tp; B1, B2, B3, and B12 are identical or different, and each represents Gp; B16 represents Cp; and B6, B10, B14, and B18 are identical or different, and each represents Ap, or a pharmacologically acceptable salt thereof for treating diseases in which telomerase is involved, such as cancer.

    摘要翻译: 1.一种由式E1-B1-B2-B3-B4-E2(Ⅰ)表示的端粒酶抑制型ENA寡核苷酸化合物,其中,E1表示式R1-表示的基团。 E2表示由式-B7-R2表示的基团; B4,B5和B8是相同或不同的,并且各自表示T

    P; B1,B2,B3和B12相同或不同,并且各自表示G < B16表示C p 和B6,B10,B14和B18相同或不同,并且各自表示用于治疗涉及端粒酶的疾病例如癌症的Aβ或其药理学上可接受的盐。

    Sample chamber for a spectro photometer
    5.
    发明授权
    Sample chamber for a spectro photometer 失效
    光谱仪的样品室

    公开(公告)号:US5307155A

    公开(公告)日:1994-04-26

    申请号:US830364

    申请日:1992-01-31

    CPC分类号: G01N21/01 G01N21/59 G01N21/86

    摘要: A spectro photometer deflects a measuring beam off its original axis to pass through a long sample, and returns the measuring beam to its final direction after passing through the sample. The sample is guided along a path which is clear of a reference beam of the spectro photometer. This arrangement permits double-beam measurement of long samples, with good signal-to-noise ratio. Deflection is accomplished using a plurality of mirrors.

    摘要翻译: 光谱光度计将测量光束偏离其原始轴线,以通过长样品,并在通过样品后将测量光束返回到其最终方向。 样品沿着远离光谱光度计的参考光束的路径被引导。 这种布置允许长样品的双光束测量,具有良好的信噪比。 使用多个反射镜实现偏转。

    Wavelength driving device for monochromators
    8.
    发明授权
    Wavelength driving device for monochromators 失效
    单色仪波长驱动装置

    公开(公告)号:US4668092A

    公开(公告)日:1987-05-26

    申请号:US801825

    申请日:1985-11-26

    申请人: Osamu Ando

    发明人: Osamu Ando

    IPC分类号: G01J3/06 G01J3/18

    CPC分类号: G01J3/06

    摘要: A wavelength driving device for use in monochromators which comprises an optical element for dispersing light into different wavelengths, means for supporting the optical element for rotation about a first axis, a stepping motor, a first toothed pulley of a relatively small diameter connected to the output shaft of the stepping motor for simultaneous stepwise rotation therewith, a first gear of a relatively large diameter fixed to the supporting means for simultaneous rotation about the first axis, a second gear of a relatively small diameter mounted for rotation about a second axis and meshing with the first gear, a second toothed pulley of a relatively large diameter fixed to the second gear for simultaneous rotation about the second axis, a toothed belt connecting the first and second toothed pulleys, and circuit means for controlling the rotation of the stepping motor.

    摘要翻译: 一种用于单色器的波长驱动装置,包括用于将光分散到不同波长的光学元件,用于支撑围绕第一轴旋转的光学元件的装置,步进电机,连接到输出端的相对小直径的第一齿形皮带轮 所述步进电机的轴与所述步进电动机同时逐步旋转,固定到所述支撑装置上以相对于所述第一轴线同时旋转的相对较大直径的第一齿轮,相对小直径的第二齿轮,其安装成绕第二轴线旋转并与 第一齿轮,固定到第二齿轮上的相对较大直径的第二齿形皮带轮,用于围绕第二轴线同时旋转,连接第一和第二齿形皮带轮的齿形带以及用于控制步进电动机旋转的电路装置。

    Substituted cycloalkene derivative
    9.
    再颁专利
    Substituted cycloalkene derivative 有权
    取代的环烯烃衍生物

    公开(公告)号:USRE43858E1

    公开(公告)日:2012-12-11

    申请号:US13224745

    申请日:2006-09-13

    IPC分类号: A61K31/335 C07D317/72

    摘要: A compound of formula (I) Wherein X, Y, ring A, ring B, l, m, R1, R2, R4 and R5 are as defined herein, to supress intracellular signal transduction or cell activation induced by endotoxin and to suppress cell responses due to the intracellular signal transduction and cell activation such as an excess generation of inflammatory mediators such as TNF-α, pharmacologically acceptable salts therefor, a preparation method therefor, and a medicament containing the aforementioned substituted cycloalkene derivative as an active ingredient which is superior in prophylaxis and/or treatment of diseases such as sepsis (septic shock, disseminated intravascular coagulation, multiple organ failure and the like), that are associated with intracellular signal transduction or cell activation induced by endotoxin and to cell responses to the intracellular signal transduction and cell activation.

    摘要翻译: 式(I)化合物其中X,Y,环A,环B,l,m,R 1,R 2,R 4和R 5如本文所定义,以抑制由内毒素诱导的细胞内信号转导或细胞活化并抑制细胞反应 由于细胞内信号转导和细胞活化,例如过量产生炎症介质如TNF-α,其药理学上可接受的盐,其制备方法,以及含有上述取代的环烯烃衍生物作为活性成分的药物,其优于 与细胞内信号转导或由内毒素诱导的细胞活化以及对细胞内信号转导和细胞的细胞反应相关的诸如败血症(败血症休克,弥散性血管内凝血,多器官功能衰竭等)的疾病的预防和/或治疗 激活。

    Electrophotographic photoreceptor comprising a photosensitive layer
containing a naphthylhydrazone compound
    10.
    发明授权
    Electrophotographic photoreceptor comprising a photosensitive layer containing a naphthylhydrazone compound 失效
    包含含有萘基腙化合物的感光层的电子照相感光体

    公开(公告)号:US5290649A

    公开(公告)日:1994-03-01

    申请号:US246916

    申请日:1988-09-16

    IPC分类号: C09B26/02 G03G5/06

    CPC分类号: C09B26/02 G03G5/0668

    摘要: An electrophotographic photoreceptor is formed by a photosensitive layer containing a naphtylhydrazone compound of the formula: ##STR1## wherein X and Y are independently a hydrogen atom, lower alkyl group, lower alkoxy group, phenoxy group or arylalkoxy group; R.sup.1 is a naphtyl group; R.sup.2 is a hydrogen atom, lower alkyl group, allyl group, substituted or unsubstituted phenyl group, or aralkyl group; and l and m are 1 or 2. The photoreceptor thus formed is not only highly sensitive but resistant to ozone deterioration, which markedly improves the durability thereof.

    摘要翻译: 电子照相感光体由含有下式的化合物(*化学结构*)的感光层形成,其中X和Y独立地为氢原子,低级烷基,低级烷氧基,苯氧基或芳基烷氧基; R1是萘基; R2是氢原子,低级烷基,烯丙基,取代或未取代的苯基或芳烷基; l和m为1或2.由此形成的感光体不仅高度敏感,而且耐臭氧劣化,这显着提高了其耐久性。